Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | CDC25B | P30305 | 1/20 | 0.33 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.33 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.33 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.31 |
| ▸ | MAOA | P21397 | 1/20 | 0.31 |
| ▸ | MAOB | P27338 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3259174 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CDC25BTRIM24TRIM33CYP2A6 | |
| SCHEMBL868287 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CDC25BTRIM24TRIM33CYP2A6 | |
| SCHEMBL3262868 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CDC25BTRIM24TRIM33CYP2A6 | |
| SCHEMBL3259171 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CDC25BTRIM24TRIM33CYP2A6 | |
| SCHEMBL4619035 | 0.98 | ALDH1A1 (0.48) | ALDH1A1CDC25BTRIM24TRIM33CA1 | |
| SCHEMBL4619030 | 0.98 | ALDH1A1 (0.48) | ALDH1A1CDC25BTRIM24TRIM33CA1 | |
| SCHEMBL3334082 | 0.90 | — | — | |
| SCHEMBL3682073 | 0.86 | ALDH1A1 (0.38) | ALDH1A1CDC25BTRIM24TRIM33 | |
| SCHEMBL2678350 | 0.84 | ALDH1A1 (0.44) | ALDH1A1CDC25BTRIM24TRIM33CA1 | |
| SCHEMBL2678345 | 0.84 | ALDH1A1 (0.44) | ALDH1A1CDC25BTRIM24TRIM33CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4520867-A2 | ARTICLES FORMED OF PULP BASE MATERIALS WITH MODULATED SCENT RELEASE | Enviroscent, Inc. (US) | 2025-03-12 | — | — | EP | disclosed |
| US-20250049978-A1 | Articles Formed of Pulp Base Materials With Modulated Scent Release | ENVIROSCENT, INC. | 2025-02-13 | — | — | US | disclosed |
| WO-2024242850-A1 | DISSOLVABLE NANOCELLULOSE SHEET | BERKLEY MEDICAL RESOURCES, INC. (US) | 2024-11-28 | — | — | WO | disclosed |
| CN-118995350-A | Soluble nanocellulose sheet | 伯克利医疗资源股份有限公司 | 2024-11-22 | — | — | CN | disclosed |
| US-20240384470-A1 | DISSOLVABLE NANOCELLULOSE SHEET | BERKLEY MEDICAL RESOURCES, INC. (US) | 2024-11-21 | — | — | US | disclosed |
| EP-4464763-A1 | DISSOLVABLE NANOCELLULOSE SHEET | Berkley Medical Resources, Inc. (US) | 2024-11-20 | — | — | EP | disclosed |
| US-12109340-B2 | Formed three-dimensional matrix and associated coating providing modulated release of volatile compositions | ENVIROSCENT, INC. (US) | 2024-10-08 | — | — | US | disclosed |
| EP-3518992-B1 | ARTICLES FORMED OF PULP BASE MATERIALS WITH MODULATED SCENT RELEASE | ENVIROSCENT INC (US) | 2024-08-28 | — | — | EP | disclosed |
| US-11931487-B2 | Articles formed of pulp base materials with modulated scent release | ENVIROSCENT, INC. (US) | 2024-03-19 | — | — | US | disclosed |
| US-20230404895-A1 | Enhanced Deposition Compositions For Personal Care Actives | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2023-12-21 | — | — | US | disclosed |
| WO-2002036088-A1 | METHODS OF FRAGRANCING A SURFACE | THE PROCTER & GAMBLE COMPANY (US) | 2002-05-10 | — | — | WO | disclosed |
| WO-2002036089-A2 | METHODS AND COMPOSITIONS FOR IMPROVED FRAGRANCING OF A SURFACE | THE PROCTER & GAMBLE COMPANY (US) | 2002-05-10 | — | — | WO | disclosed |
| EP-1203577-A1 | Methods of fragrancing a surface | THE PROCTER & GAMBLE COMPANY (US) | 2002-05-08 | — | — | EP | disclosed |
| EP-1203578-A1 | Methods and compositions for improved fragrancing of a surface | The Procter & Gamble Company (US) | 2002-05-08 | — | — | EP | disclosed |
| WO-2002034225-A1 | FRAGRANCE COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2002-05-02 | — | — | WO | disclosed |
| WO-2002034227-A1 | FRAGRANCE COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2002-05-02 | — | — | WO | disclosed |
| WO-2002034226-A1 | FRAGRANCE COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2002-05-02 | — | — | WO | disclosed |
| WO-2001093815-A2 | FRAGRANCE COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2001-12-13 | — | — | WO | disclosed |
| WO-2001093814-A2 | FRAGRANCE COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2001-12-13 | — | — | WO | disclosed |
| WO-2001093813-A2 | FRAGRANCE COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2001-12-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230404895-A1 | Enhanced Deposition Compositions For Personal Care Actives | PLOD3, POLR1C, KRT18 | ALDH1A1 2744/4885CDC25B 3836/4885TRIM24 3116/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.